Skip to main content
Top
Published in: Journal of Inflammation 1/2015

Open Access 01-12-2015 | Research

TNF-alpha and IL-6 inhibit apolipoprotein A-IV production induced by linoleic acid in human intestinal Caco2 cells

Authors: Xiaoming Li, Min Xu, Min Liu, Yong Ji, Zongfang Li

Published in: Journal of Inflammation | Issue 1/2015

Login to get access

Abstract

Background

Apolipoprotein A-IV (apoA-IV) is a protein mainly synthesized by enterocytes in the intestine. Its gene expression is suppressed during fasting and stimulated during active fat absorption. Chronic feeding of a high-fat (HF) diet abolishes the differential expression between fasting and fat-feeding and therefore may contribute to diet-induced obesity since apoA-IV is a potent satiety factor. It is well established that the circulating pro-inflammatory cytokines TNF-α and IL-6 are increased by HF feeding.

Methods

To determine whether pro-inflammatory cytokines are involved in the diminished response of apoA-IV gene expression to fat-feeding, different concentrations of linoleic acid (LA), an important dietary fatty acid, was used to stimulate apoA-IV expression in human intestinal Caco2 cells. Cells were pre-treated with or without human recombinant TNF-α, IL-6 or their combination before the addition of LA. Real-time PCR and ELISA were used to detect and quantify RNA transcripts and proteins of apoA-IV and the cytokines.

Results

LA stimulated gene and protein expression of apoA-IV in a dose and time dependent manner. Pre-treatment with the cytokines for 72 h significantly inhibited the increased expression of apoA-IV gene and protein induced by LA. Furthermore, the cytokines, especially TNF-α, also positively up-regulate the cytokine themselves in Caco2 cells.

Conclusions

Our data indicate that the pro-inflammatory cytokines may be responsible for the reduced apoA-IV production in response to fat feeding. Because of apoA-IV’s role in satiety, we propose the inhibitory effect of circulating pro-inflammatory cytokines on apoA-IV production contributes to diet-induced obesity.
Literature
1.
go back to reference Calder PC, Ahluwalia N, Brouns F, Buetler T, Clement K, Cunningham K, et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr. 2011;106:S1−+.CrossRef Calder PC, Ahluwalia N, Brouns F, Buetler T, Clement K, Cunningham K, et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr. 2011;106:S1−+.CrossRef
2.
go back to reference Kuller LH. Dietary fat and chronic diseases: epidemiologic overview. J Am Diet Assoc. 1997;97:S9–15.CrossRefPubMed Kuller LH. Dietary fat and chronic diseases: epidemiologic overview. J Am Diet Assoc. 1997;97:S9–15.CrossRefPubMed
3.
go back to reference Bisgaier CL, Sachdev OP, Megna L, Glickman RM. Distribution of apolipoprotein-a-Iv in human-plasma. J Lipid Res. 1985;26:11–25.PubMed Bisgaier CL, Sachdev OP, Megna L, Glickman RM. Distribution of apolipoprotein-a-Iv in human-plasma. J Lipid Res. 1985;26:11–25.PubMed
4.
go back to reference Weinberg RB. Apolipoprotein A-IV polymorphisms and diet-gene interactions. Curr Opin Lipidol. 2002;13:125–34.CrossRefPubMed Weinberg RB. Apolipoprotein A-IV polymorphisms and diet-gene interactions. Curr Opin Lipidol. 2002;13:125–34.CrossRefPubMed
5.
go back to reference Liu M, Doi T, Shen L, Woods SC, Seeley RJ, Zheng SQ, et al. Intestinal satiety protein apolipoprotein AIV is synthesized and regulated in rat hypothalamus. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1382–7.PubMed Liu M, Doi T, Shen L, Woods SC, Seeley RJ, Zheng SQ, et al. Intestinal satiety protein apolipoprotein AIV is synthesized and regulated in rat hypothalamus. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1382–7.PubMed
6.
go back to reference Qin XF, Swertfeger DK, Zheng SQ, Hui DY, Tso P. Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation. Am J Physiol Heart Circ Physiol. 1998;43:H1836–40. Qin XF, Swertfeger DK, Zheng SQ, Hui DY, Tso P. Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation. Am J Physiol Heart Circ Physiol. 1998;43:H1836–40.
7.
go back to reference Recalde D, Ostos MA, Badell E, Garcia-Otin AL, Pidoux J, Castro G, et al. Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide. Arterioscler Thromb Vasc Biol. 2004;24:756–61.CrossRefPubMed Recalde D, Ostos MA, Badell E, Garcia-Otin AL, Pidoux J, Castro G, et al. Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide. Arterioscler Thromb Vasc Biol. 2004;24:756–61.CrossRefPubMed
8.
go back to reference Wang F, Kohan AB, Kindel TL, Corbin KL, Nunemaker CS, Obici S, et al. Apolipoprotein A-IV improves glucose homeostasis by enhancing insulin secretion. Proc Natl Acad Sci U S A. 2012;109:9641–6.CrossRefPubMedCentralPubMed Wang F, Kohan AB, Kindel TL, Corbin KL, Nunemaker CS, Obici S, et al. Apolipoprotein A-IV improves glucose homeostasis by enhancing insulin secretion. Proc Natl Acad Sci U S A. 2012;109:9641–6.CrossRefPubMedCentralPubMed
9.
go back to reference Li XM, Xu M, Wang F, Kohan AB, Haas MK, Yang Q, et al. Apolipoprotein A-IV reduces hepatic gluconeogenesis through nuclear receptor NR1D1. J Biol Chem. 2014;289:2396–404.CrossRefPubMedCentralPubMed Li XM, Xu M, Wang F, Kohan AB, Haas MK, Yang Q, et al. Apolipoprotein A-IV reduces hepatic gluconeogenesis through nuclear receptor NR1D1. J Biol Chem. 2014;289:2396–404.CrossRefPubMedCentralPubMed
10.
go back to reference Weinberg RB, Dantzker C, Patton CS. Sensitivity of serum apolipoprotein A-Iv levels to changes in dietary-Fat content. Gastroenterology. 1990;98:17–24.PubMed Weinberg RB, Dantzker C, Patton CS. Sensitivity of serum apolipoprotein A-Iv levels to changes in dietary-Fat content. Gastroenterology. 1990;98:17–24.PubMed
11.
go back to reference Kalogeris TJ, Painter RG. Adaptation of intestinal production of apolipoprotein A-IV during chronic feeding of lipid. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1155–61.PubMed Kalogeris TJ, Painter RG. Adaptation of intestinal production of apolipoprotein A-IV during chronic feeding of lipid. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1155–61.PubMed
13.
14.
go back to reference Park EJ, Lee JH, Yu GY, He GB, Ali SR, Holzer RG, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell. 2010;140:197–208.CrossRefPubMedCentralPubMed Park EJ, Lee JH, Yu GY, He GB, Ali SR, Holzer RG, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell. 2010;140:197–208.CrossRefPubMedCentralPubMed
15.
go back to reference Ding SL, Chi MM, Scull BP, Rigby R, Schwerbrock NMJ, Magness S, et al. High-Fat Diet: Bacteria Interactions Promote Intestinal Inflammation Which Precedes and Correlates with Obesity and Insulin Resistance in Mouse. Plos One. 2010;5:e1219. Ding SL, Chi MM, Scull BP, Rigby R, Schwerbrock NMJ, Magness S, et al. High-Fat Diet: Bacteria Interactions Promote Intestinal Inflammation Which Precedes and Correlates with Obesity and Insulin Resistance in Mouse. Plos One. 2010;5:e1219.
16.
go back to reference Ji Y, Sakata Y, Yang Q, Li XM, Xu M, Yoder S, et al. Activation of rat intestinal mucosal mast cells by fat absorption. Am J Physiol Gastrointest Liver Physiol. 2012;302:G1292–300.CrossRefPubMedCentralPubMed Ji Y, Sakata Y, Yang Q, Li XM, Xu M, Yoder S, et al. Activation of rat intestinal mucosal mast cells by fat absorption. Am J Physiol Gastrointest Liver Physiol. 2012;302:G1292–300.CrossRefPubMedCentralPubMed
17.
go back to reference Navarro MA, Carpintero R, Acin S, Arbones-Mainar J, Calleja L, Carnicer R, et al. Immune-regulation of the apolipoprotein A-I/C-III/A-IV gene cluster in experimental inflammation. Cytokine. 2005;31:52–63.CrossRefPubMed Navarro MA, Carpintero R, Acin S, Arbones-Mainar J, Calleja L, Carnicer R, et al. Immune-regulation of the apolipoprotein A-I/C-III/A-IV gene cluster in experimental inflammation. Cytokine. 2005;31:52–63.CrossRefPubMed
18.
go back to reference Liu M, Shen L, Liu Y, Tajima D, Sakai R, Woods SC, et al. Diurnal rhythm of apolipoprotein A-IV in rat hypothalamus and its relation to food intake and corticosterone. Endocrinology. 2004;145:3232–8.CrossRefPubMed Liu M, Shen L, Liu Y, Tajima D, Sakai R, Woods SC, et al. Diurnal rhythm of apolipoprotein A-IV in rat hypothalamus and its relation to food intake and corticosterone. Endocrinology. 2004;145:3232–8.CrossRefPubMed
19.
go back to reference Luchoomun J, Hussain MM. Assembly and secretion of chylomicrons by differentiated Caco-2 cells - Nascent triglycerides and preformed phospholipids are preferentially used for lipoprotein assembly. J Biol Chem. 1999;274:19565–72.CrossRefPubMed Luchoomun J, Hussain MM. Assembly and secretion of chylomicrons by differentiated Caco-2 cells - Nascent triglycerides and preformed phospholipids are preferentially used for lipoprotein assembly. J Biol Chem. 1999;274:19565–72.CrossRefPubMed
20.
go back to reference Black DD, Wang H, Hunter F, Zhan R. Intestinal expression of apolipoprotein A-IV and C-III is coordinately regulated by dietary lipid in newborn swine. Biochem Biophys Res Commun. 1996;221:619–24.CrossRefPubMed Black DD, Wang H, Hunter F, Zhan R. Intestinal expression of apolipoprotein A-IV and C-III is coordinately regulated by dietary lipid in newborn swine. Biochem Biophys Res Commun. 1996;221:619–24.CrossRefPubMed
21.
go back to reference Yoshida H, Miura S, Kishikawa H, Hirokawa M, Nakamizo H, Nakatsumi RC, et al. Fatty acids enhance GRO/CINC-1 and interleukin-6 production in rat intestinal epithelial cells. J Nutr. 2001;131:2943–50.PubMed Yoshida H, Miura S, Kishikawa H, Hirokawa M, Nakamizo H, Nakatsumi RC, et al. Fatty acids enhance GRO/CINC-1 and interleukin-6 production in rat intestinal epithelial cells. J Nutr. 2001;131:2943–50.PubMed
22.
go back to reference Qin XF, Tso P. The role of apolipoprotein AIV on the control of food intake. Curr Drug Targets. 2005;6:145–51.CrossRefPubMed Qin XF, Tso P. The role of apolipoprotein AIV on the control of food intake. Curr Drug Targets. 2005;6:145–51.CrossRefPubMed
23.
go back to reference Liu M, Shen L, Liu Y, Woods SC, Seeley RJ, Alessio DD, et al. Obesity induced by a high-fat diet downregulates apolipoprotein A-IV gene expression in rat hypothalamus. Am J Physiol Endocrinol Metab. 2004;287:E366–70.CrossRefPubMed Liu M, Shen L, Liu Y, Woods SC, Seeley RJ, Alessio DD, et al. Obesity induced by a high-fat diet downregulates apolipoprotein A-IV gene expression in rat hypothalamus. Am J Physiol Endocrinol Metab. 2004;287:E366–70.CrossRefPubMed
24.
go back to reference Dashti N. Synthesis and secretion of nascent lipoprotein particles. Prog Lipid Res. 1991;30:219–30.CrossRefPubMed Dashti N. Synthesis and secretion of nascent lipoprotein particles. Prog Lipid Res. 1991;30:219–30.CrossRefPubMed
25.
go back to reference Field FJ, Born E, Mathur SN. Triacylglycerol-rich lipoprotein cholesterol is derived from the plasma membrane in CaCo-2 cells. J Lipid Res. 1995;36:2651–60.PubMed Field FJ, Born E, Mathur SN. Triacylglycerol-rich lipoprotein cholesterol is derived from the plasma membrane in CaCo-2 cells. J Lipid Res. 1995;36:2651–60.PubMed
26.
go back to reference Hussain MM, Kancha RK, Zhou ZY, Luchoomun J, Zu HY, Bakillah A. Chylomicron assembly and catabolism: role of apolipoproteins and receptors. Biochim Biophys Acta, Lipids Lipid Metab. 1996;1300:151–70.CrossRef Hussain MM, Kancha RK, Zhou ZY, Luchoomun J, Zu HY, Bakillah A. Chylomicron assembly and catabolism: role of apolipoproteins and receptors. Biochim Biophys Acta, Lipids Lipid Metab. 1996;1300:151–70.CrossRef
27.
go back to reference Levy E, Mehran M, Seidman E. Caco-2 cells as a model for intestinal lipoprotein synthesis and secretion. FASEB J. 1995;9:626–35.PubMed Levy E, Mehran M, Seidman E. Caco-2 cells as a model for intestinal lipoprotein synthesis and secretion. FASEB J. 1995;9:626–35.PubMed
28.
go back to reference Kern PA, Ranganathan S, Li CL, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2001;280:E745–51.PubMed Kern PA, Ranganathan S, Li CL, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2001;280:E745–51.PubMed
29.
go back to reference Syrenicz A, Garanty-Bogacka B, Syrenicz M, Gebala A, Walczak M. Low-grade systemic inflammation and the risk of type 2 diabetes in obese children and adolescents. Neuroendocrinol Lett. 2006;27:453–8.PubMed Syrenicz A, Garanty-Bogacka B, Syrenicz M, Gebala A, Walczak M. Low-grade systemic inflammation and the risk of type 2 diabetes in obese children and adolescents. Neuroendocrinol Lett. 2006;27:453–8.PubMed
30.
go back to reference Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab. 1998;83:2907–10.PubMed Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab. 1998;83:2907–10.PubMed
31.
go back to reference Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796–808.CrossRefPubMedCentralPubMed Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796–808.CrossRefPubMedCentralPubMed
32.
go back to reference Xu HY, Barnes GT, Yang Q, Tan Q, Yang DS, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821–30.CrossRefPubMedCentralPubMed Xu HY, Barnes GT, Yang Q, Tan Q, Yang DS, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821–30.CrossRefPubMedCentralPubMed
33.
go back to reference Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med. 2005;11:191–8.CrossRefPubMed Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med. 2005;11:191–8.CrossRefPubMed
34.
go back to reference Yuan M. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikk beta (vol 293, pg 1673, 2001). Science. 2002;295:277.CrossRef Yuan M. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikk beta (vol 293, pg 1673, 2001). Science. 2002;295:277.CrossRef
Metadata
Title
TNF-alpha and IL-6 inhibit apolipoprotein A-IV production induced by linoleic acid in human intestinal Caco2 cells
Authors
Xiaoming Li
Min Xu
Min Liu
Yong Ji
Zongfang Li
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Journal of Inflammation / Issue 1/2015
Electronic ISSN: 1476-9255
DOI
https://doi.org/10.1186/s12950-015-0069-0

Other articles of this Issue 1/2015

Journal of Inflammation 1/2015 Go to the issue